NASDAQ:NIKI | Free Cash Flow | Niki BioSolutions, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$535,719.00
2024-12-31$119,646.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$1.84M
2024-12-31-$1.19M
2023-12-31-$7.72M$3,015.00-$7.73M
2022-12-31-$12.32M$186,916.00-$12.51M
2021-12-31-$14.65M$131,750.00-$14.78M
2020-12-31-$15.93M$161,314.00-$16.09M-327.09%
2019-12-31-$13.38M$837,062.00-$14.22M
2018-12-31-$10.04M$5.65M-$15.68M